A Conversation with SV Health Investors on Medtech Investment and Jonathan P. Gertler, BioVentures MedTech Funds [Podcast]
MedTech Investing with Paul LaViolette, SV Health Investors
“I have a deep belief that medtech and healthtech are going to carry us forward to markedly improve delivery and quality of healthcare.” - Jonathan P. Gertler, MD
For years, biotech has been the dominant theme in life sciences development, offering a great deal in treatment advances and in terms of investing versatility and returns potential. But with promising system solutions serving broader swaths of patients, medtech is resurging. Medtech investment has grown dramatically over time, with scale and diversification capable of weathering economic storms and fueling expansion in the markets.